Osteosarcoma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 67: Line 67:


===Other Diagnostic Studies===
===Other Diagnostic Studies===
No additional tests are recommended for the diagnosis of melanoma.


==References==
==References==

Revision as of 15:41, 29 September 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Osteosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteosarcoma overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteosarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteosarcoma overview

CDC on Osteosarcoma overview

Osteosarcoma overview in the news

Blogs on Osteosarcoma overview

Directions to Hospitals Treating Osteosarcoma

Risk calculators and risk factors for Osteosarcoma overview

Overview

Bone cancer is a malignant (cancerous) tumor of the bone that destroys normal bone tissue (1). Not all bone tumors are malignant. In fact, benign (noncancerous) bone tumors are more common than malignant ones. Both malignant and benign bone tumors may grow and compress healthy bone tissue, but benign tumors do not spread, do not destroy bone tissue, and are rarely a threat to life.

Malignant tumors that begin in bone tissue are called primary bone cancer. Cancer that metastasizes (spreads) to the bones from other parts of the body, such as the breast, lung, or prostate, is called metastatic cancer, and is named for the organ or tissue in which it began. Primary bone cancer is far less common than cancer that spreads to the bones.

There are three types of bone cancer:

  • Osteosarcoma - develops in growing bones, usually between ages 10 and 25
  • Chondrosarcoma - starts in cartilage, usually after age 50
  • Ewing's sarcoma - begins in nerve tissue in bone marrow of young people, often after treatment of another condition with radiation or chemotherapy

Osteosarcoma is the most common type of malignant bone cancer, accounting for 35% of primary bone malignancies. There is a preference for the metaphyseal region of tubular long bones. 50% of cases occur around the knee. It is a malignant connective (soft) tissue tumor whose neoplastic cells present osteoblastic differentiation and form tumoral bone.

Classification

Osteosarcomas may be classified into several subtypes based on differentiation, location within the bone, and histological variants.

Pathophysiology

The osteosarcomas may be localized at the end of the long bones (commonly in the metaphysis). Most often it affects the upper end of tibia or humerus, or lower end of femur. On gross pathology, areas of bone formation, hemorrhage, fibrosis, and cystic degeneration on cut surface are characteristic findings of osteosarcoma. On microscopic histopathological analysis, presence of osteoid within the tumor, pleomorphic cells, anaplastic cells, and atypical mitoses are characteristic findings of osteosarcoma.

Causes

There are no established causes for osteosarcoma.

Differential Diagnosis

Osteosarcoma must be differentiated from Ewing's sarcoma, Giant cell tumors, Malignant fibrous histiocytoma, Osteomyelitis, and aneurysmal bone cyst.

Epidemiology and Demographics

Risk Factors

The common risk factors in the development of osteosarcoma are radiation to bones, alkylating antineoplastic agents, paget disease, Multiple hereditary osteochondromas, Fibrous dysplasia, Bloom syndrome,Rothmund-Thomson syndrome, and Li-Fraumeni syndrome.

Screening

Screening for osteosarcoma is not recommended.

Natural History, Complications and Prognosis

Common complications of osteosarcoma include pathologic fracture and metastasis. The 5-year survival rate of osteosarcoma after adequate therapy is approximately 60-80%. Pretreatment factors that influence outcome of the osteosarcoma are primary tumor site, size of the primary tumor, and site of metastasis.

Diagnosis

Staging

According to the American Joint Committee on Cancer (AJCC), there are four stages of osteosarcoma based on the size of primary tumor, metastasis, involvement of lymph nodes, and grade of the tumor.

History and Symptoms

The most common symptoms of osteosarcoma include bone pain that may be worse at night, swelling, and redness at the site of the tumor. The affected bone is not as strong as normal bones and may fracture with minor trauma (a pathological fracture).

Physical Examination

Physical examination findings will depend on the location of the osteosarcoma. Common physical examination findings of osteosarcoma are localized swelling and tenderness.

Laboratory Findings

Laboratory tests for osteosarcoma include complete blood count (CBC), blood chemistry studies such as serum alkaline phosphatase and lactate dehydrogenase.

Biopsy

Biopsy of osteosarcoma is important for confirming the diagnosis and for determining histologic subtype.[1] Biopsy may be performed percutaneously with fine- or wide-bore needles, or through a formal incision.

X Ray

On x-ray, osteosarcoma is characterized by medullary and cortical bone destruction, periosteal reaction, tumor matrix calcification and soft tissue mass.[2]

CT

The role of CT scan in osteosarcoma is predominantly in assisting biopsy and staging, but adds little to plain radiography and MRI in direct assessment of the tumor.[3]

MRI

On MRI, osteosarcoma is characterized by intermediate intensity of soft tissue and low signal intensity of ossified components on T1. High signal intensity of soft tissue and low signal imtensity of ossified components on T2. Considerable contrast enhancement of solid components on T1 contrast.

Other Imaging Findings

Bone scan in osteosarcoma is used to observe abnormal areas of bone and metastasis.[4]

Other Diagnostic Studies

No additional tests are recommended for the diagnosis of melanoma.

References

  1. Osteosarcoma. surgwiki. http://www.surgwiki.com/wiki/Diseases_of_bone_and_joints#SURGERY_4
  2. Osteosarcoma. Dr Amir Rezaee ◉ and Dr Frank Gaillard ◉ et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/osteosarcoma
  3. Osteosarcoma. Dr Amir Rezaee ◉ and Dr Frank Gaillard ◉ et al. http://radiopaedia.org/articles/osteosarcoma
  4. Osteosarcoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/bone/diagnosis/?region=bc

Template:WH Template:WS